Gene Report
Approved Symbol | BAX |
---|---|
Approved Name | BCL2-associated X protein |
Symbol Alias | BCL2L4 |
Location | 19q13.3-q13.4 |
Position | chr19:49458117-49465055 (+) |
External Links |
Entrez Gene: 581 Ensembl: ENSG00000087088 UCSC: uc002plf.1 HGNC ID: 959 |
No. of Studies (Positive/Negative) | 1(1/0) |
Type | Literature-origin |
Genetic/epigenetic locus | Protein and other molecule | Cell and molecular pathway | Neural system | Cognition and behavior | Symptoms and signs | Environment | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Network loading ...
Note:
1. The different color of the nodes denotes the level of the nodes.
Genetic/Epigenetic Locus | Protein and Other Molecule | Cell and Molecular Pathway | Neural System | Cognition and Behavior | Symptoms and Signs | Environment | MDD |
2. User can drag the nodes to rearrange the layout of the network. Click the node will enter the report page of the node. Right-click will show also the menus to link to the report page of the node and remove the node and related edges. Hover the node will show the level of the node and hover the edge will show the evidence/description of the edge.
3. The network is generated using Cytoscape Web
Approved Name | UniportKB | No. of Studies (Positive/Negative) | Source | |
---|---|---|---|---|
Apoptosis regulator BAX | Q07812 | 0(0/0) | Gene mapped |
Literature-origin GO terms | ||||
ID | Name | Type | Evidence | |
---|---|---|---|---|
GO:0006915 | apoptotic process | biological process | IDA[9219694]; TAS |
Gene mapped GO terms | ||||
ID | Name | Type | Evidence | |
---|---|---|---|---|
GO:0009566 | fertilization | biological process | IEA | |
GO:0005757 | mitochondrial permeability transition pore complex | cellular component | IDA[9843949] | |
GO:0044445 | cytosolic part | cellular component | IEA | |
GO:0001777 | T cell homeostatic proliferation | biological process | IEA | |
GO:1990009 | retinal cell apoptotic process | biological process | IMP[10702418] | |
GO:0051259 | protein oligomerization | biological process | IDA[19074440] | |
GO:0007281 | germ cell development | biological process | IEA | |
GO:0035234 | germ cell programmed cell death | biological process | IEA | |
GO:0006808 | regulation of nitrogen utilization | biological process | IEA | |
GO:0001836 | release of cytochrome c from mitochondria | biological process | IDA[9843949] | |
GO:0001822 | kidney development | biological process | IEA | |
GO:0042803 | protein homodimerization activity | molecular function | IDA[16608847]; IPI[9111042] | |
GO:0002352 | B cell negative selection | biological process | IEA | |
GO:0002262 | myeloid cell homeostasis | biological process | IEA | |
GO:0043653 | mitochondrial fragmentation involved in apoptotic process | biological process | IDA[12499352] | |
GO:0002904 | positive regulation of B cell apoptotic process | biological process | IEA | |
GO:0010332 | response to gamma radiation | biological process | IEA | |
GO:0005789 | endoplasmic reticulum membrane | cellular component | IDA[16424160] | |
GO:0008637 | apoptotic mitochondrial changes | biological process | IDA[9843949] | |
GO:0045136 | development of secondary sexual characteristics | biological process | IEA | |
GO:0097193 | intrinsic apoptotic signaling pathway | biological process | IDA[16462759] | |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | biological process | IEA | |
GO:0048597 | post-embryonic camera-type eye morphogenesis | biological process | IEA | |
GO:0060068 | vagina development | biological process | IEA | |
GO:0009636 | response to toxin | biological process | IDA[16307838] | |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | biological process | IMP[11350920] | |
GO:0001782 | B cell homeostasis | biological process | IEA | |
GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c | biological process | IDA[15214043] | |
GO:0032976 | release of matrix enzymes from mitochondria | biological process | IDA[9843949] | |
GO:0046982 | protein heterodimerization activity | molecular function | IPI[9111042] | |
GO:0043496 | regulation of protein homodimerization activity | biological process | IDA[9111042] | |
GO:0048678 | response to axon injury | biological process | IEA | |
GO:0006974 | response to DNA damage stimulus | biological process | IEA | |
GO:0048515 | spermatid differentiation | biological process | IEA | |
GO:0043497 | regulation of protein heterodimerization activity | biological process | IPI[9111042] | |
GO:0035108 | limb morphogenesis | biological process | IEA | |
GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response | biological process | IMP[16645094] | |
GO:0001541 | ovarian follicle development | biological process | IEA | |
GO:0046666 | retinal cell programmed cell death | biological process | IEA | |
GO:0008289 | lipid binding | molecular function | IDA[14522999] | |
GO:0048087 | positive regulation of developmental pigmentation | biological process | IEA | |
GO:0005515 | protein binding | molecular function | IPI[16113678] | |
GO:0032091 | negative regulation of protein binding | biological process | IDA[9388232] | |
GO:0097136 | Bcl-2 family protein complex | cellular component | IDA | |
GO:0071310 | cellular response to organic substance | biological process | IEA | |
GO:0060011 | Sertoli cell proliferation | biological process | IEA | |
GO:0005634 | nucleus | cellular component | IMP[15102863] | |
GO:0001974 | blood vessel remodeling | biological process | IEA | |
GO:0043525 | positive regulation of neuron apoptotic process | biological process | IDA[15637643] | |
GO:0009651 | response to salt stress | biological process | IEA | |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | biological process | IDA[9843949] | |
GO:0048147 | negative regulation of fibroblast proliferation | biological process | IEA | |
GO:0001101 | response to acid | biological process | IEA | |
GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | biological process | IEA | |
GO:0005739 | mitochondrion | cellular component | IDA[17823127] | |
GO:0051434 | BH3 domain binding | molecular function | IDA; IPI[17052454] | |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | biological process | IEA | |
GO:0060058 | positive regulation of apoptotic process involved in mammary gland involution | biological process | IEA | |
GO:0042802 | identical protein binding | molecular function | IPI[16113678] | |
GO:0005783 | endoplasmic reticulum | cellular component | IDA[16424160] | |
GO:0006309 | apoptotic DNA fragmentation | biological process | IMP[11350920] | |
GO:0005741 | mitochondrial outer membrane | cellular component | TAS | |
GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | biological process | IMP[14963330] | |
GO:0019048 | virus-host interaction | biological process | IEA | |
GO:0043065 | positive regulation of apoptotic process | biological process | IMP[17289999] | |
GO:0032461 | positive regulation of protein oligomerization | biological process | IDA[19805544] | |
GO:0042475 | odontogenesis of dentin-containing tooth | biological process | IEA | |
GO:0051402 | neuron apoptotic process | biological process | IEA | |
GO:0006917 | induction of apoptosis | biological process | IDA[11912183]; IMP[11350920]; NAS[9920818] | |
GO:0006927 | transformed cell apoptotic process | biological process | IMP[10739008] | |
GO:0006922 | cleavage of lamin involved in execution phase of apoptosis | biological process | IMP[11350920] | |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | IDA[11912183]; IMP[11350920] | |
GO:0001783 | B cell apoptotic process | biological process | IDA[16424160] | |
GO:0002358 | B cell homeostatic proliferation | biological process | IEA | |
GO:0043524 | negative regulation of neuron apoptotic process | biological process | IEA | |
GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | biological process | IEA | |
GO:0008053 | mitochondrial fusion | biological process | IDA[14769861] | |
GO:0005829 | cytosol | cellular component | IDA[17823127]; TAS | |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | biological process | IMP[16645094] | |
GO:0006687 | glycosphingolipid metabolic process | biological process | IEA | |
GO:0097190 | apoptotic signaling pathway | biological process | IDA[16424160] | |
GO:0046930 | pore complex | cellular component | IDA[9219694] | |
GO:0021987 | cerebral cortex development | biological process | IEA | |
GO:0051260 | protein homooligomerization | biological process | IDA[14522999] | |
GO:0015267 | channel activity | molecular function | IDA[9219694] | |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | biological process | IDA[14963330] | |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | biological process | IEA | |
GO:0021854 | hypothalamus development | biological process | IEA | |
GO:0060041 | retina development in camera-type eye | biological process | IEA | |
GO:0051881 | regulation of mitochondrial membrane potential | biological process | IDA[9843949] | |
GO:0034644 | cellular response to UV | biological process | IEA | |
GO:0051726 | regulation of cell cycle | biological process | IEA | |
GO:0001764 | neuron migration | biological process | IEA | |
GO:0048873 | homeostasis of number of cells within a tissue | biological process | IEA |
Gene mapped KEGG pathways | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
hsa05200 | pathways in_cancer | Pathways in cancer | ||
hsa05014 | amyotrophic lateral_sclerosis_als | Amyotrophic lateral sclerosis (ALS) | Amyotrophic lateral sclerosis (ALS) is a progressive, lethal...... Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, leading to paralysis of voluntary muscles. Mutant superoxide dismutase 1 (SOD1), as seen in some familial amyotrophic lateral sclerosis (FALS) cases, may be toxic because it is unstable, forming aggregates in the motor neuron cytoplasm, axoplasm and mitochondria. Within mitochondria, mutant SOD1 may interfere with the anti-apoptotic function of Bcl-2, affect mitochondrial import by interfering with the translocation machinery (TOM/TIM), and generate toxic free radicals (ROS) via aberrant superoxide chemistry. These changes may then result in abnormal mitochondrial energy metabolism, Ca2+ handling, and release of pro-apoptotic factors. Reactive oxygen species (ROS), produced within mitochondria, inhibit the function of EAAT2, the main glial glutamate transporter protein, responsible for most of the reuptake of synaptically released glutamate. Glutamate excess causes neurotoxicity by increasing intracellular calcium, which enhances oxidative stress and mitochondrial damage. Mutant SOD1 can also trigger oxidative reactions by various means including by increasing levels of peroxynitrite, which can then cause damage through the formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. Nitration may target neurofilament proteins, disrupting their phosphorylation and affecting axonal transport. Collectively, these mechanisms (or a combination thereof) are predicted to disturb cellular homeostasis (within glial and/or motor neurons), ultimately triggering motor neuron death. More... | |
hsa05016 | huntingtons disease | Huntington's disease | Huntington disease (HD) is an autosomal-dominant neurodegene...... Huntington disease (HD) is an autosomal-dominant neurodegenerative disorder that primarily affects medium spiny striatal neurons (MSN). HD is caused by a CAG repeat expansion in the IT15 gene, which results in a long stretch of polyglutamine close to the amino-terminus of the HD protein huntingtin (Htt). Mutant Htt (mHtt) has effects both in the cytoplasm and in the nucleus. In the cytoplasm, full-length mHtt can interfere with BDNF vesicular transport on microtubules. This mutant protein also may lead to abnormal endocytosis and secretion in neurons, because normal Htt form a complex with the proteins Hip1, clathrin and AP2 that are involved in endocytosis. In addition, mHtt affects Ca2+ signaling by sensitizing InsP3R1 to activation by InsP3, stimulating NR2B/NR1 NMDAR activity, and destabilizing mitochondrial Ca2+ handling. As a result, stimulation of glutamate receptors leads to supranormal Ca2+ responses in HD MSN and mitochondrial Ca2+ overload. The mHtt translocates to the nucleus, where it forms intranuclear inclusions, though they are not primarily responsible for toxicity. Nuclear toxicity is believed to be caused by interference with gene transcription, leading to loss of transcription of neuroprotective molecules such as BDNF. While mHtt binds to p53 and upregulates levels of nuclear p53 as well as p53 transcriptional activity. Augmented p53 mediates mitochondrial dysfunction. More... | |
hsa05210 | colorectal cancer | Colorectal cancer | Classically, colorectal cancer (CRC) has been believed to de...... Classically, colorectal cancer (CRC) has been believed to develop from normal mucosa through the premalignant adenoma by the step-wise accumulation of mutations. All CRC display either microsatellite instability (MSI) or chromosome instability (CIN). MSI occurs in 15% of colon cancers and results from inactivation of the DNA mismatch repair (MMR) system by either MMR gene mutations or hypermethylation of the MLH1 promoter. MSI promotes tumorigenesis through generating mutations in target genes that possess coding microsatellite repeats, such as beta-catenin, TGFBR2 and BAX. CIN is found in the majority of colon cancers and leads to a different pattern of gene alterations that contribute to tumor formation. Genes involved in CIN are those coding for APC, K-ras, SMAD4 and p53. More... | |
hsa04210 | apoptosis | Apoptosis | Apoptosis is a genetically controlled mechanisms of cell dea...... Apoptosis is a genetically controlled mechanisms of cell death involved in the regulation of tissue homeostasis. The 2 major pathways of apoptosis are the extrinsic (Fas and other TNFR superfamily members and ligands) and the intrinsic (mitochondria-associated) pathways, both of which are found in the cytoplasm. The extrinsic pathway is triggered by death receptor engagement, which initiates a signaling cascade mediated by caspase-8 activation. Caspase-8 both feeds directly into caspase-3 activation and stimulates the release of cytochrome c by the mitochondria. Caspase-3 activation leads to the degradation of cellular proteins necessary to maintain cell survival and integrity. The intrinsic pathway occurs when various apoptotic stimuli trigger the release of cytochrome c from the mitochondria (independently of caspase-8 activation). Cytochrome c interacts with Apaf-1 and caspase-9 to promote the activation of caspase-3. Recent studies point to the ER as a third subcellular compartment implicated in apoptotic execution. Alterations in Ca2+ homeostasis and accumulation of misfolded proteins in the ER cause ER stress. Prolonged ER stress can result in the activation of BAD and/or caspase-12, and execute apoptosis. More... | |
hsa04115 | p53 signaling_pathway | p53 signaling pathway | p53 activation is induced by a number of stress signals, inc...... p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways. More... | |
hsa05020 | prion diseases | Prion diseases | Prion diseases, also termed transmissible spongiform encepha...... Prion diseases, also termed transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative diseases that affect humans and a number of other animal species. The etiology of these diseases is thought to be associated with the conversion of a normal protein, PrPC, into an infectious, pathogenic form, PrPSc. The conversion is induced by prion infections (for example, variant Creutzfeldt-Jakob disease (vCJD), iatrogenic CJD, Kuru), mutations (familial CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia (FFI)) or unknown factors (sporadic CJD (sCJD)), and is thought to occur after PrPC has reached the plasma membrane or is re-internalized for degradation. The PrPSc form shows greater protease resistance than PrPC and accumulates in affected individuals, often in the form of extracellular plaques. Pathways that may lead to neuronal death comprise oxidative stress, regulated activation of complement, ubiquitin-proteasome and endosomal-lysosomal systems, synaptic alterations and dendritic atrophy, corticosteroid response, and endoplasmic reticulum stress. In addition, the conformational transition could lead to the lost of a beneficial activity of the natively folded protein, PrPC. More... | |
hsa04722 | neurotrophin signaling_pathway | Neurotrophin signaling pathway | Neurotrophins are a family of trophic factors involved in di...... Neurotrophins are a family of trophic factors involved in differentiation and survival of neural cells. The neurotrophin family consists of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4). Neurotrophins exert their functions through engagement of Trk tyrosine kinase receptors or p75 neurotrophin receptor (p75NTR). Neurotrophin/Trk signaling is regulated by connecting a variety of intracellular signaling cascades, which include MAPK pathway, PI-3 kinase pathway, and PLC pathway, transmitting positive signals like enhanced survival and growth. On the other hand, p75NTR transmits both positive and nagative signals. These signals play an important role for neural development and additional higher-order activities such as learning and memory. More... |
Gene mapped BioCarta pathways | ||||
ID | Name | Brief Description | Full Description | |
---|---|---|---|---|
MITOCHONDRIA_PATHWAY | mitochondria pathway | Role of Mitochondria in Apoptotic Signaling | Mitochondria participate in apoptotic signaling pathways thr...... Mitochondria participate in apoptotic signaling pathways through the release of mitochondrial proteins into the cytoplasm. Cytochrome c, a key protein in electron transport, is released from mitochondria in response to apoptotic signals, and activates Apaf-1, a protease released from mitochondria. Activated Apaf-1 activates caspase-9 and the rest of the caspase pathway. Smac/DIABLO is released from mitochondria and inhibits IAP proteins that normally interact with caspase-9 to inhibit apoptosis. Apoptosis regulation by Bcl-2 family proteins occurs as family members form complexes that enter the mitochondrial membrane, regulating the release of cytochrome c and other proteins. TNF family receptor that cause apoptosis directly activate the caspase cascade, but can also activate Bid, a Bcl-2 family member, which activates mitochondria-mediated apoptosis. Bax, another Bcl-2 family member, is activated by this pathway to localize to the mitochondrial membrane and increase its permeability, releasing cytochre c and other mitochondrial proteins. Bcl-2 and Bcl-xL prevent pore formation, blocking apoptosis. AIF (Apoptosis inducing factor) is another mitochondrial factor that is released into the cytoplasm to induce apoptosis. AIF-induced apoptosis is important during development but is not caspase dependent. More... | |
CHEMICAL_PATHWAY | chemical pathway | Apoptotic Signaling in Response to DNA Damage | The cellular activation of the caspase cascade resulting in ...... The cellular activation of the caspase cascade resulting in cell death is triggered by chemical damage to DNA which stimulates a sequence resulting in the cleavage of Bid in a manner similar to the binding of so called death-receptors or directly initiates the permeability transition of the mitochondrial membrane. The permiability transition releases several factors including cytochrome c, AIF and other factors in to the cytoplasm. Cytochrome c, a key protein in electron transport, is released from mitochondria in response to apoptotic signals, and activates Apaf-1, a protease released from mitochondria. Activated Apaf-1 activates caspase-9 and the rest of the caspase cascade. The caspases are a class of cysteine proteases that includes several representatives involved in apoptosis. The caspases convey the apoptotic signal in a proteolytic cascade, with caspases cleaving and activating other caspases that then degrade other cellular targets that lead to cell death. More... | |
BAD_PATHWAY | bad pathway | Regulation of BAD phosphorylation | The function of the pro-apoptotic molecule BAD is regulated ...... The function of the pro-apoptotic molecule BAD is regulated by phosphorylation of three sites (ser 112,136 and 155). Phosphorylation at these sites results in loss of the ability of BAD to heterodimerize with the survival proteins BCL-XL or BCL-2. Phosphorylated BAD binds to 14-3-3 and is sequestered in the cytoplasm. While ser-136 phosphorylation is concordant with the activation of Akt, Ser-112 phosphorylation requires activation of the Ras-MAPK pathway. BAD Ser 155 was found to be a major site of phosphorylation induced following stimulation by growth factors and prevented by protein kinase A inhibitors. More... | |
P53HYPOXIA_PATHWAY | p53hypoxia pathway | Hypoxia and p53 in the Cardiovascular system | Hypoxic stress, like DNA damage, induces p53 protein accumul...... Hypoxic stress, like DNA damage, induces p53 protein accumulation and p53-dependent apoptosis in oncogenically transformed cells. Unlike DNA damage, hypoxia does not induce p53-dependent cell cycle arrest, suggesting that p53 activity is differentially regulated by these two stresses. Hypoxia induces p53 protein accumulation, but in contrast to DNA damage, hypoxia fails to induce endogenous downstream p53 effector mRNAs and proteins, such as p21, Bax, CIP1, WAF1 etc. Hypoxia does not inhibit the induction of p53 target genes by ionizing radiation, indicating that p53-dependent transactivation requires a DNA damage-inducible signal that is lacking under hypoxic treatment alone. The phosphatidylinositol 3-OH-kinase-Akt pathway inhibits p53-mediated transcription and apoptosis. Mdm2, a ubiquitin ligase for p53, plays a central role in regulation of the stability of p53 and serves as a good substrate for Akt. Mdm-2 targets the p53 tumor suppressor for ubiquitin-dependent degradation by the proteasome, but, in addition, the p53 transcription factor induces Mdm-2, thus, establishing a feedback loop. Hypoxia or DNA damage by abrogating binding of HIF-1 with VHL and p53 with Mdm-2, respectively, leads to stabilization and accumulation transcriptionally active HIF-1 and p53. At the molecular level, DNA damage induces the interaction of p53 with the transcriptional activator p300 as well as with the transcriptional corepressor mSin3A. In contrast, hypoxia primarily induces an interaction of p53 with mSin3A, but not with p300. More... | |
CERAMIDE_PATHWAY | ceramide pathway | Ceramide Signaling Pathway | Over 1,000 papers and reviews have been written about the ro...... Over 1,000 papers and reviews have been written about the role of ceramide in the production of programmed cell death or apoptosis. Ceramide is a sphingosine-based lipid-signaling molecule involved in the regulation of cellular differentiation, proliferation, and apoptosis. This diagram represents some of the current understanding of the cascades that couple ceramide to specific signaling pathways. These cascades illustrate that ceramide can be a growth stimulus or proapototic signal. The ultimate ceramide action is determined within the context of other stimuli and by the subcellular topology of its production and is cell-type specific. There are 2 forms of sphingomyelinase, acid (acid-sphingomyelinase:A-SMase) and neutral (neutral-sphingomyelinase N-SMase), that can produce ceramide. TNF-alpha can stimulate either form of sphingomyelinase as can other death receptors. Different domanis of TNF-alpha stimulate the different Smases. N-SMase stimulation is enhanced by the receptor for activated-C kinase 1 (RACK1). The activity of each form is dependent on the local intracellular pH. In the illustration the forms are seperated to reduce confusion however ceramide produced by either method can stimulate either cascade depending on the presence of specific co-factors and activators. A-SMase has been recognized as one of the required molecules to mediate proapoptotic signalling in cell death induced by a diverse array of stresses such as H2O2, Heat, UV exposure and Radiation. ROS generation in mitochondria activates caspase-3 via cooperation of cytochrome c, Aif and caspase-9 and stimulates or increases ceramide generation through A-SMase in a proaptotic activation cycle. Caspase-3 further increases its own activation by proteolytically cleaving ceramide inhibited catalase which is an inhibitor of ROS generation. Ceramide-activated protein kinase(CARK) also known as Kinase Supressor of RAS (KSR) activity is in some cases the switch point in the balance between proapoptotic and antiapoptotic signals and is also cell-type specific. In endothelial cells for example the activation of KSR is required for apoptosis. In contrast in epithelial cells activation of KSR is required for cell proliferation. An additional switch point is the availability of Bad in the cell. Activation of KSR leads to further mitocondrial stimulation or association with RAS and activation of the Raf1 cascade leading to proliferation or differentiation. More... | |
P53_PATHWAY | p53 pathway | p53 Signaling Pathway | p53 is a transcription factor who's activity is regulated by...... p53 is a transcription factor who's activity is regulated by phosphorylation. The function is p53 is to keep the cell from progressing through the cell cycle if there is damage to DNA present. It may do this in multiple ways from holding the cell at a checkpoint until repairs can be made to causing the cell to enter apoptosis if the damage cannot be repaired. The critical role of p53 is evidenced by the fact that it is mutated in a very large fraction of tumors from nearly all sources. More... |
Gene mapped Reactome pathways | |||
ID | Name | Description | |
---|---|---|---|
REACT_578 | apoptosis | Apoptosis is a distinct form of cell death that is functiona...... Apoptosis is a distinct form of cell death that is functionally and morphologically different from necrosis. Nuclear chromatin condensation, cytoplasmic shrinking, dilated endoplasmic reticulum, and membrane blebbing characterize apoptosis in general. Mitochondria remain morphologically unchanged. In 1972 Kerr et al introduced the concept of apoptosis as a distinct form of cell-death, and the mechanisms of various apoptotic pathways are still being revealed today. The two principal pathways of apoptosis are (1) the Bcl-2 inhibitable or intrinsic pathway induced by various forms of stress like intracellular damage, developmental cues, and external stimuli and (2) the caspase 8/10 dependent or extrinsic pathway initiated by the engagement of death receptors The caspase 8/10 dependent or extrinsic pathway is a death receptor mediated mechanism that results in the activation of caspase-8 and caspase-10. Activation of death receptors like Fas/CD95, TNFR1, and the TRAIL receptor is promoted by the TNF family of ligands including FASL (APO1L OR CD95L), TNF, LT-alpha, LT-beta, CD40L, LIGHT, RANKL, BLYS/BAFF, and APO2L/TRAIL. These ligands are released in response to microbial infection, or as part of the cellular, humoral immunity responses during the formation of lymphoid organs, activation of dendritic cells, stimulation or survival of T, B, and natural killer (NK) cells, cytotoxic response to viral infection or oncogenic transformation. The Bcl-2 inhibitable or intrinsic pathway of apoptosis is a stress-inducible process, and acts through the activation of caspase-9 via Apaf-1 and cytochrome c. The rupture of the mitochondrial membrane, a rapid process involving some of the Bcl-2 family proteins, releases these molecules into the cytoplasm. Examples of cellular processes that may induce the intrinsic pathway in response to various damage signals include: auto reactivity in lymphocytes, cytokine deprivation, calcium flux or cellular damage by cytotoxic drugs like taxol, deprivation of nutrients like glucose and growth factors like EGF, anoikis, transactivation of target genes by tumor suppressors including p53. In many non-immune cells, death signals initiated by the extrinsic pathway are amplified by connections to the intrinsic pathway. The connecting link appears to be the truncated BID (tBID) protein a proteolytic cleavage product mediated by caspase-8 or other enzymes. More... | |
REACT_964 | intrinsic pathway_for_apoptosis | The intrinsic (Bcl-2 inhibitable or mitochondrial) pathway o...... The intrinsic (Bcl-2 inhibitable or mitochondrial) pathway of apoptosis functions in response to various types of intracellular stress including growth factor withdrawal, DNA damage, unfolding stresses in the endoplasmic reticulum and death receptor stimulation. Following the reception of stress signals, proapoptotic BCL-2 family proteins are activated and subsequently interact with and inactivate antiapoptotic BCL-2 proteins. This interaction leads to the destabilization of the mitochondrial membrane and release of apoptotic factors. These factors induce the caspase proteolytic cascade, chromatin condensation, and DNA fragmentation, ultimately leading to cell death. The key players in the Intrinsic pathway are the Bcl-2 family of proteins that are critical death regulators residing immediately upstream of mitochondria. The Bcl-2 family consists of both anti- and proapoptotic members that possess conserved alpha-helices with sequence conservation clustered in BCL-2 Homology (BH) domains. Proapoptotic members are organized as follows: 1. Multidomain BAX family proteins such as BAX, BAK etc. that display sequence conservation in their BH1-3 regions. These proteins act downstream in mitochondrial disruption. 2. BH3-only proteins such as BID,BAD, NOXA, PUMA,BIM, and BMF have only the short BH3 motif. These act upstream in the pathway, detecting developmental death cues or intracellular damage. Anti-apoptotic members like Bcl-2, Bcl-XL and their relatives exhibit homology in all segments BH1-4. One of the critical functions of BCL-2/BCL-XL proteins is to maintain the integrity of the mitochondrial outer membrane. More... |
BAX related interactors from protein-protein interaction data in HPRD (count: 19)
Gene | Interactor | Interactor in MK4MDD? | Experiment Type | PMID | |
---|---|---|---|---|---|
BAX | BCL2 | No | in vitro;in vivo;yeast 2-hybrid | 9111042 , 8358790 , 9463381 , 16642033 , 17097560 , 15231068 | |
BAX | BAK1 | No | in vivo | 11571294 | |
BAX | SFN | No | in vivo | 11574543 | |
BAX | PPP1CA | No | in vitro;in vivo | 17274640 | |
BAX | BCL2L1 | Yes | in vitro;in vivo;yeast 2-hybrid | 11283018 , 9111042 , 9153240 , 9742125 , 15131699 | |
BAX | BCL2L10 | No | in vivo | 11278245 | |
BAX | PMAIP1 | No | in vivo | 15705586 | |
BAX | NOL3 | No | in vivo | 15383280 | |
BAX | MOAP1 | No | in vitro;in vivo | 11060313 | |
BAX | YWHAQ | No | in vitro;in vivo | 12426317 | |
BAX | BCL2A1 | No | in vivo;yeast 2-hybrid | 10753914 | |
BAX | VDAC1 | No | in vitro | 12767928 , 9843949 | |
BAX | BID | No | in vivo;yeast 2-hybrid | 15574335 | |
BAX | ERN1 | No | in vitro;in vivo | 16645094 | |
BAX | KCNA3 | No | in vivo | 18818304 | |
BAX | SH3GLB1 | No | in vitro;in vivo;yeast 2-hybrid | 11259440 , 11161816 | |
BAX | SLC25A4 | No | in vivo;yeast 2-hybrid | 9748162 | |
BAX | BBC3 | No | yeast 2-hybrid | 15574335 | |
BAX | MCL1 | No | in vitro | 10837489 , 15077116 |